I 
112TH CONGRESS 
1ST SESSION H. R. 2194 
To provide grants to better understand and reduce gestational diabetes, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 15, 2011 
Mr. ENGEL (for himself, Mr. BURGESS, Mr. ACKERMAN, Mr. RANGEL, Mr. 
GONZALEZ, Ms. LEE of California, and Mr. KING of New York) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce 
A BILL 
To provide grants to better understand and reduce 
gestational diabetes, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Gestational Diabetes 
Act of 2011’’ or the ‘‘GEDI Act’’. 
SEC. 2. GESTATIONAL DIABETES. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by adding after section 
317H the following: 
VerDate Mar 15 2010 
01:25 Jun 18, 2011
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2194.IH
H2194
pwalker on DSK5TPTVN1PROD with BILLS
‘‘SEC. 317H–1. GESTATIONAL DIABETES. 
‘‘(a) UNDERSTANDING
AND MONITORING GESTA-
TIONAL DIABETES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, in consultation with the Di-
abetes Mellitus Interagency Coordinating Committee 
established under section 429 and representatives of 
appropriate national health organizations, shall de-
velop a multisite gestational diabetes research 
project within the diabetes program of the Centers 
for Disease Control and Prevention to expand and 
enhance surveillance data and public health research 
on gestational diabetes. 
‘‘(2) AREAS TO BE ADDRESSED.—The research 
project developed under paragraph (1) shall ad-
dress— 
‘‘(A) procedures to establish accurate and 
efficient systems for the collection of gestational 
diabetes data within each State and common-
wealth, territory, or possession of the United 
States; 
‘‘(B) the progress of collaborative activities 
with the National Vital Statistics System, the 
National Center for Health Statistics, and 
State health departments with respect to the 
VerDate Mar 15 2010 
01:25 Jun 18, 2011
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2194.IH
H2194
pwalker on DSK5TPTVN1PROD with BILLS
standard birth certificate, in order to improve 
surveillance of gestational diabetes; 
‘‘(C) postpartum methods of tracking 
women with gestational diabetes after delivery 
as well as targeted interventions proven to 
lower the incidence of type 2 diabetes in that 
population; 
‘‘(D) variations in the distribution of diag-
nosed and undiagnosed gestational diabetes, 
and of impaired fasting glucose tolerance and 
impaired fasting glucose, within and among 
groups of women; and 
‘‘(E) factors and culturally sensitive inter-
ventions that influence risks and reduce the in-
cidence of gestational diabetes and related com-
plications during childbirth, including cultural, 
behavioral, racial, ethnic, geographic, demo-
graphic, socioeconomic, and genetic factors. 
‘‘(3) REPORT.—Not later than 2 years after the 
date of the enactment of this section, and annually 
thereafter, the Secretary shall generate a report on 
the findings and recommendations of the research 
project including prevalence of gestational diabetes 
in the multisite area and disseminate the report to 
the appropriate Federal and non-Federal agencies. 
VerDate Mar 15 2010 
01:25 Jun 18, 2011
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2194.IH
H2194
pwalker on DSK5TPTVN1PROD with BILLS